Integral Molecular, Inc. Announces Patent Allowance for its Membrane Protein Lipoparticle Technology

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide highly-concentrated membrane proteins in their native conformation for antibody and drug discovery applications focused on membrane protein targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters.

MORE ON THIS TOPIC